Back

Histological profiling, viral analysis, and follow-up of inflammatory cardiomyopathy in adults supported by long-term left ventricular assist device therapy

12 May 2024 (11:00 - 11:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - treatment 6 Ventricular Assist Devices HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Maria J Ruiz Cano

Heart and Diabetes Center NRW, Bad Oeynhausen (Germany)

6 More presentations in this session

Presentation thumbnail
The impact of sodium glucose transporter 2 inhibitors on cardiac remodeling in a large cohort of unselected patients
Doctor V. Copeland (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Warfarin and aspirin versus warfarin alone in patients with HeartMate 3 left ventricular assist device: a systematic review and meta-analysis.
Mr L. Rezende De Freitas (BR)
Abstract Slides Video
Presentation thumbnail
Impact of hemodynamic optimization on reducing pulmonary pressures and adverse clinical events in left ventricular assist device recipients with elevated pulmonary vascular resistance
Professor M. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Impact of an extended infectiological standard operating procedure on the outcome of patients with VAD-associated infections
Mr Y. Streef (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Clinical and echocardiographic effects of vericiguat therapy in advanced heart failure patinets undergoing LVAD support
Associate Professor G. Poglajen (Ljubljana, SI)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - treatment 6

The Event

Event poster

Heart Failure 2024

12 May 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Changes in myocardial inflammation and viral infection in adults with inflammatory cardiomyopathy following long-term left ventricular assist device
thumbnail
Congress Presentation
Clinical features of chronic active myocarditis in patients with heart failure and reduced left ventricular ejection fraction
thumbnail
Congress Presentation
The diagnostic value of endomyocardial biopsy in the era of precision medicine: data from over 8,000 patients with comprehensive biopsy diagnostics

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources